|
|
|
|
LEADER |
00000nas a2200000 4500 |
001 |
000148 |
003 |
AR-CdUAS |
005 |
20210809203945.0 |
008 |
100307s19239999xxu|||p_r|||||||||||eng|d |
022 |
|
|
|a 0022-3565
|
030 |
|
|
|a JPETAB
|
040 |
|
|
|c AR-CdUAS
|
210 |
1 |
0 |
|a J.Pharmacol.Exp.Ther.
|
245 |
0 |
0 |
|a JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS /
|c The American Society for Pharmacology and Experimental Therapeutics.
|
260 |
|
|
|a Baltimore, Estados Unidos :
|b Williams and Wilkins,
|c 1923-
|e 351 West Camden Street, MD 21201-2436, Baltimore, US
|
310 |
|
|
|a 4v 3n
|
362 |
1 |
|
|a 1923-
|
500 |
|
|
|a Indizado en: Ind.Med
|
500 |
|
|
|a Indizado en: Curr.Cont
|
500 |
|
|
|a Indizado en: Excerpta Medica
|
500 |
|
|
|a Responsable intelectual: The American Society for Pharmacology and Experimental Therapeutics
|
541 |
|
|
|a 1923-31 Donación Bca. Mayor
|
541 |
|
|
|a 1964 Santo Vanasía, USD 46.20 (adq. en '65)
|
541 |
|
|
|a 1965 Williams & Wilkins, USD 42
|
541 |
|
|
|a 1966 Williams & Wilkins, USD 42
|
541 |
|
|
|a 1967 Santo Vanasía, USD 85.80
|
541 |
|
|
|a 1968 Santo Vanasía, USD 44.00
|
541 |
|
|
|a 1969 Santo Vanasía, USD 68.40
|
541 |
|
|
|a 1970 Santo Vanasía, USD 68.40 (v.171-176)
|
541 |
|
|
|a 1971 Santo Vanasía, USD 69.00 (v.176-179)
|
541 |
|
|
|a 1972 Santo Vanasía, USD 69.30 (v.180-183)
|
541 |
|
|
|a 1973 Maxwell, USD 60.00 (v.184-187)
|
541 |
|
|
|a 1974 Maxwell, USD 76.00 (v.188-191)
|
541 |
|
|
|a 1975 Maxwell, USD 76.00 (v.192-195)
|
541 |
|
|
|a 1976 Maxwell, USD 113.75 (v.196-199)
|
541 |
|
|
|a 1977 Maxwell, USD 116.00 (v.200-203)
|
541 |
|
|
|a 1978 Maxwell, USD 127.00 (v.204-207)
|
541 |
|
|
|a 1979 Maxwell, USD 128.00 (v.208-211)
|
541 |
|
|
|a 1980 Maxwell, USD 154.00 (v.212-215)
|
541 |
|
|
|a 1981 Maxwell, USD 189.50 (v.216-219)
|
541 |
|
|
|a 1982 Santo Vanasía, USD 212.75 (v.220-223)
|
541 |
|
|
|a 1983 Santo Vanasía, USD 231.00 (v.224-227)
|
541 |
|
|
|a 1984 Santo Vanasía, USD 260.00 (v.228-231)
|
541 |
|
|
|a 1985 Santo Vanasía, USD 275 (v.232-236)
|
541 |
|
|
|a 1992 Faxon
|
541 |
|
|
|a 1993 Faxon
|
650 |
|
4 |
|9 627
|a Quimioterapia
|
650 |
|
4 |
|9 310
|a Farmacología
|
650 |
|
4 |
|a Preparaciones farmaceuticas
|9 1611
|
650 |
|
4 |
|a Inmunofarmacología
|
650 |
|
7 |
|a Neurofarmacología
|9 511
|
650 |
|
4 |
|a Toxicología
|9 713
|
710 |
2 |
|
|a The American Society for Pharmacology and Experimental Therapeutics
|
856 |
4 |
|
|u http://jpet.aspetjournals.org/contents-by-date.0.shtml
|
866 |
|
0 |
|a 1923 v.21-22
|
866 |
|
0 |
|a 1924 v.22,23(1-3,5,6),24
|
866 |
|
0 |
|a 1925 v.24,25(1,3-6),26
|
866 |
|
0 |
|a 1926 v.26,27(1-3,5,6),30
|
866 |
|
0 |
|a 1927-28 v.30-34
|
866 |
|
0 |
|a 1931 v.41-43
|
866 |
|
0 |
|a 1947 v.89(2-4),90
|
866 |
|
0 |
|a 1948 v.93(2-4),94(1,4)
|
866 |
|
0 |
|a 1951 v.101-103
|
866 |
|
0 |
|a 1953 v.107-109
|
866 |
|
0 |
|a 1957 v.119-121
|
866 |
|
0 |
|a 1964-84 v.143-231
|
866 |
|
0 |
|a 1985 v.232
|
866 |
|
0 |
|a 1986-88 v.236-247
|
866 |
|
0 |
|a 1989 v.248,249(1)
|
866 |
|
0 |
|a 1990 v.252(1-3),253-255
|
866 |
|
0 |
|a 1991 v.257(3),258-259
|
866 |
|
0 |
|a 1992-96 v.260-279
|
866 |
|
0 |
|a 1997 v.280.
|
942 |
|
|
|c REV
|2 ddc
|
945 |
|
|
|a MCP
|d 03-04-1998
|
999 |
|
|
|c 6181
|d 6181
|